Kidney tumors represent a type of cancer that people of advanced age are more likely to develop. For this reason, it is important to exercise caution and provide diagnostic tests in the later stages of life. Medical imaging and deep learning methods are becoming increasingly attractive in this sense. Developing deep learning models to help physicians identify tumors with successful segmentation is of great importance. However, not many successful systems exist for soft tissue organs, such as the kidneys and the prostate, of which segmentation is relatively difficult. In such cases where segmentation is difficult, V-Net-based models are mostly used. This paper proposes a new hybrid model using the superior features of existing V-Net models. The model represents a more successful system with improvements in the encoder and decoder phases not previously applied. We believe that this new hybrid V-Net model could help the majority of physicians, particularly those focused on kidney and kidney tumor segmentation. The proposed model showed better performance in segmentation than existing imaging models and can be easily integrated into all systems due to its flexible structure and applicability. The hybrid V-Net model exhibited average Dice coefficients of 97.7% and 86.5% for kidney and tumor segmentation, respectively, and, therefore, could be used as a reliable method for soft tissue organ segmentation.

No abstract

Many women around the world die due to breast cancer. If breast cancer is treated in the early phase, mortality rates may significantly be reduced. Quite a number of approaches have been proposed to help in the early detection of breast cancer. A novel hybrid feature selection model is suggested in this study. This novel hybrid model aims to build an efficient feature selection method and successfully classify breast lesions. A combination of relief and binary Harris hawk optimization (BHHO) hybrid model is used for feature selection. Then, k-nearest neighbor (k-NN), support vector machine (SVM), logistic regression (LR) and naive Bayes (NB) methods are preferred for the classification task. The suggested hybrid model is tested by three different breast cancer datasets which are Wisconsin diagnostic breast cancer dataset (WDBC), Wisconsin breast cancer dataset (WBCD) and mammographic breast cancer dataset (MBCD). According to the experimental results, the relief and BHHO hybrid model improves the performance of all classification algorithms in all three datasets. For WDBC, relief-BHO-SVM model shows the highest classification rates with an of accuracy of 98.77%, precision of 97.17%, recall of 99.52%, F1-score of 98.33%, specificity of 99.72% and balanced accuracy of 99.62%. For WBCD, relief-BHO-SVM model achieves of accuracy of 99.28%, precision of 98.76%, recall of 99.17%, F1-score of 98.96%, specificity of 99.56% and balanced accuracy of 99.36%. Relief-BHO-SVM model performs the best with an accuracy of 97.44%, precision of 97.41%, recall of 98.26%, F1-score of 97.84%, specificity of 97.47% and balanced accuracy of 97.86% for MBCD. Furthermore, the relief-BHO-SVM model has achieved better results than other known approaches. Compared with recent studies on breast cancer classification, the suggested hybrid method has achieved quite good results.

In this study, from 150 individuals over the age of 30 taken no drugs, sex, age, height, weight, HDL, LDL, Triglyceride, smoking and uric acid were measured. 65 of them are normal but 85 consist of the patients. This data was transferred to the computer by processing methods of quantitative analysis. Data obtained of each patient was applied Artificial Neural Network (ANN) models. The results obtained will be classified as either normal or the patient. Using Multi Layer Perceptron (MLP) neural network, 80.4% of patient individuals and 81.8% of normal individuals were classified correctly. Using Jordan Elman neural network, 85.3% of the patient individuals and 87.8% of normal individuals were classified correctly.

Hundreds of thousands of people worldwide are diagnosed with kidney cancer each year, and this disease is more common in developed societies. Approximately 30% of patients with kidney cancer are recognized at the metastatic stage. Segmentation is an important process in the computer-aided treatment planning of kidney diseases. For this reason, more importance should be given to studies focused on segmentation as accurate segmentation is of high importance in the medical sense. This paper focuses on an improved version of the existing U-Net3D models. The aim is to assist physicians struggling with kidney segmentation. The improved U-Net3D model showed better performance than U-Net, U-Net+ResNet, and U-Net++ models, with 97.89% accurate segmentation.